Literature DB >> 9350678

Mechanisms of malnutrition in uremia.

G Guarnieri1, G Toigo, N Fiotti, B Ciocchi, R Situlin, C Giansante, A Vasile, M Carraro, L Faccini, G Biolo.   

Abstract

The pathogenesis of protein wasting in chronic renal failure is multifactorial. Potential mediators of protein catabolism in chronic uremia include anorexia, low protein-energy intake, increased cortisol and parathyroid hormone secretion, insulin resistance, metabolic acidosis and unidentified uremic toxins. In non-acidotic uremic patients the rate of protein turnover (that is, synthesis and degradation) has often been found to be decreased. Malnutrition also decreases both protein synthesis and degradation. In contrast, during acidosis protein degradation is primarily accelerated and results in rapid loss of body proteins. Cytokine concentrations have often been found increased in both dialyzed and undialyzed chronically uremic patients. Our study determined the circulating levels of TNF-alpha and of type I (60 kDa) and type II (80 kDa) soluble TNF-alpha receptors in undialyzed uremic patients, and found that their plasma levels were greatly increased. Serum creatinine correlated with TNF-alpha soluble receptors but not with the TNF-alpha. Thus, TNF-alpha is potentially an important mediator of protein wasting in chronically uremic patients. Pharmacological therapy of protein catabolism in chronic uremia may include the administration of pentoxifylline, which has been shown to decrease protein degradation by interfering with the TNF-alpha system (that is, TNF-alpha and its soluble receptors) in experimental models. Growth hormone and insulin-like growth factor-1 administration may also be beneficial in these patients, but further evaluation of the hormone effects on glucose and glutamine metabolism is called for.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9350678

Source DB:  PubMed          Journal:  Kidney Int Suppl        ISSN: 0098-6577            Impact factor:   10.545


  7 in total

1.  The utility of the IGF-I generation test in children with chronic kidney disease.

Authors:  Amira Al-Uzri; Rita D Swinford; Thuan Nguyen; Randall Jenkins; Anthony Gunsul; Svetlana S Kachan-Liu; Ron Rosenfeld
Journal:  Pediatr Nephrol       Date:  2013-09-07       Impact factor: 3.714

2.  Relationship between some prognostic markers of HD patients and serum erythropoietin, insulin-like growth factor-1, leptin, parathormone and testosterone.

Authors:  M Majdan; J Kotarski; A Ksiaźek; A Grzebalska
Journal:  Int Urol Nephrol       Date:  1999       Impact factor: 2.370

3.  Contribution of increased HMG-CoA reductase gene expression to hypercholesterolemia in experimental chronic renal failure.

Authors:  Michal Chmielewski; Elzbieta Sucajtys; Julian Swierczynski; Boleslaw Rutkowski; Wojciech Bogusławski
Journal:  Mol Cell Biochem       Date:  2003-04       Impact factor: 3.396

4.  Malnutrition-inflammation-atherosclerosis syndrome in Chronic Kidney disease.

Authors:  Pragna Rao; G C Reddy; A S Kanagasabapathy
Journal:  Indian J Clin Biochem       Date:  2008-10-01

Review 5.  Nutritional and anti-inflammatory interventions in chronic heart failure.

Authors:  Kamyar Kalantar-Zadeh; Stefan D Anker; Tamara B Horwich; Gregg C Fonarow
Journal:  Am J Cardiol       Date:  2008-06-02       Impact factor: 2.778

6.  Insulin resistance is a significant determinant of sarcopenia in advanced kidney disease.

Authors:  Serpil M Deger; Jennifer R Hewlett; Jorge Gamboa; Charles D Ellis; Adriana M Hung; Edward D Siew; Cindy Mamnungu; Feng Sha; Aihua Bian; Thomas G Stewart; Naji N Abumrad; T Alp Ikizler
Journal:  Am J Physiol Endocrinol Metab       Date:  2018-06-12       Impact factor: 4.310

7.  Effects of a new mixture of essential amino acids (Aminotrofic(®)) in malnourished haemodialysis patients.

Authors:  S G Sukkar; F Gallo; C Borrini; A Vaccaro; C Marchello; R Boicelli; C Borgarelli; P Solari; C E Ratto; G Ravera
Journal:  Med J Nutrition Metab       Date:  2012-06-22
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.